About Juniper Biomedical
Juniper Biomedical is a company based in Worcester (United States) founded in 2019 by Mario Romero Ortega and David N Constantine. Juniper Biomedical has raised $2 million across 2 funding rounds from investors including NIH, Aatma Capital and Beacon Angels. Juniper Biomedical offers products and services including Neuromodulation Platform. Juniper Biomedical operates in a competitive market with competitors including Minze Health, INNOVO, Jude, Starling Medical and inContAlert, among others.
- Headquarter Worcester, United States
- Founders Mario Romero Ortega, David N Constantine
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2 M (USD)
in 2 rounds
-
Latest Funding Round
$1 M (USD), Grant
May 10, 2024
-
Investors
NIH
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Juniper Biomedical
Juniper Biomedical offers a comprehensive portfolio of products and services, including Neuromodulation Platform.
Implantable technology for treating pelvic health conditions.
Funding Insights of Juniper Biomedical
Juniper Biomedical has successfully raised a total of $2M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Juniper Biomedical
Juniper Biomedical has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Aatma Capital and Beacon Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in fast-growing startups by Beacon Angels.
|
Locked | Locked | Locked | |
|
Angel Network for companies based in Boston
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked |
Investor details for Juniper Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Juniper Biomedical
Investment portfolio details for Juniper Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Juniper Biomedical
Detailed financials for Juniper Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Juniper Biomedical Comparisons
Peer comparison for Juniper Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Juniper Biomedical
Juniper Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Minze Health, INNOVO, Jude, Starling Medical and inContAlert, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnosis and monitoring solutions for voiding disorders are offered.
|
|
| Locked | Locked | Locked |
Women's urinary incontinence is managed by wearable pelvic floor trainers.
|
|
| Locked | Locked | Locked |
Jude is focused on bladder health and protection products.
|
|
| Locked | Locked | Locked |
AI-based platform is developed for urinary tract infection detection.
|
|
| Locked | Locked | Locked |
Wearable sensor and mobile app for bladder monitoring are provided.
|
Detailed competitors of Juniper Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Juniper Biomedical
Complete news archive for Juniper Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Juniper Biomedical
Juniper Biomedical was founded in 2019 and raised its 1st funding round 5 years after it was founded.
Juniper Biomedical is headquartered in Worcester, United States. It is registered at Worcester, Massachusetts, United States.
David N Constantine is the current CEO of Juniper Biomedical. They have also founded this company.
Juniper Biomedical is a funded company, having raised a total of $2M across 2 funding rounds to date.
Juniper Biomedical was founded in 2019 in Worcester, United States, within the biomedical sector. A platform is operated to deliver therapy for pelvic health conditions through neuromodulation techniques. Normal neuromuscular function is restored in damaged pelvic floor tissue, while bladder activity is calmed. Treatment is focused on urinary incontinence, bowel incontinence, pelvic pain, sexual dysfunction, and related issues, with services accessible via the domain juniperbiomedical.com.
Juniper Biomedical's top competitors include Minze Health, INNOVO and Starling Medical.
Juniper Biomedical offers Neuromodulation Platform.
Juniper Biomedical has 5 investors. Key investors include NIH, Aatma Capital, Beacon Angels, Hub Angels, and Auroral Holdings.